Business Wire

Alipay+ Partners with Global Brands in #MoneyCannotBuy Initiative to Attract E-Wallet Users across Asia

29.9.2023 04:43:00 EEST | Business Wire | Press release

Share

Alipay+ today launches the #MoneyCannotBuy marketing initiative, a series of social media campaigns and special rewards, as the provider of cross-border digital payments and marketing solutions teams with global merchants in bringing a unique travel experience to Asia’s e-wallet users.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230928554669/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

With the debut treat unveiled in Dubai, a group of lucky e-wallet users would win round-trip flights in Dubai to find out the poems they submitted through an earlier Alipay+ social media campaign are projected onto the Burj Khalifa to light up the sky. (Photo: Business Wire)

#MoneyCannotBuy features major social media campaigns and special promotion from over 100 brands worldwide ranging from major theme parks to shopping malls, luxury retailers and major airports, for mobile-savvy travelers.

In China and beyond, travelers are seeking more memorable and unique travel experiences overseas. As part of the #MoneyCannotBuy campaign, Alipay+ is also hosting some 30 lucky e-wallet users from Malaysia, South Korea and Thailand on a Dream Tour, to share the excitement of the Asian Games and experience using their home e-wallets in China.

In-app offers for Alipay and other major e-wallet users

The initiative comes as Alipay+ has unveiled a series of special promotions for consumers globally, including Alipay users, for China’s longest public holiday, also known as Golden Week, which bridges over to fall and winter travel seasons.

On top of the #MoneyCannotBuy partner deals, Alipay users can also enjoy in-app car rental services across 200 countries and regions, extra 20% tax refund from major retailers in France, Italy and Spain, as well as other promotions offered by global merchants and tourism agencies.

Paralleled promotion and offers are also available to users of other Alipay+ partner e-wallets, including AlipayHK (Hong Kong SAR, China), GCash (The Philippines), TrueMoney (Thailand) and Touch ‘n Go eWallet among others. The offers range from coupons and free milk tea at Printemps in Paris to 10% off at Seoul's Noryangjin Fish Market.

2023 has been a year of major breakthroughs for Alipay+. Created as a suite of cross-border mobile payment and marketing solutions by Ant Group, Alipay+ now works with about 30 leading e-wallets. With its recent extension into the Chinese mainland, the service now connects tens of millions of merchants in 56 markets to over 1.4 billion payment accounts in Asia and beyond. Consumers enjoy seamless payment and a broad choice of deals using their preferred payment methods while travelling abroad. Small and medium-sized businesses may use Alipay+ digital tools to enhance efficiency and achieve omni-channel growth.

Alipay+ outbound tourism campaign this fall debuts in Dubai with Mid-Autumn rewards

As one of Chinese travelers’ new favorite destinations, Dubai’s downtown shopping malls, such as Galeries Lafayette, Bloomingdale's and Harvey Nichols, are rolling out 15-30% discounts to attract Chinese consumers. Alipay users can also enjoy perks like free massage from Galeries Lafayette when they book a session through the app.

A group of lucky e-wallet users from Alipay, AlipayHK (Hong Kong SAR China), Mpay (Macao SAR China) and OCBC (Singapore) even won round-trip flights and accommodation in Dubai. They also found the poems they submitted through an earlier Alipay+ social media campaign projected onto the 828-metre commanding Burj Khalifa to light up the sky.

The poems are presented alongside a 3-minute branding video of Alipay+ at the world’s tallest building in celebration of the Mid-Autumn Festival, a traditional festival of family and friends’ reunion under the full moon. The video showcases the importance of connectedness and heart-to-heart reunion through the lens of a rabbit traveling around the world in search of the moon.

The same branding video and poems will also be featured spontaneously at Aurora Plaza and Citibank Plaza on the Bund in Shanghai. For more fun, an underground train in Hangzhou has been revamped as a time tunnel to various hot destinations to mark the embarkment of the Golden Week and the #MoneyCannotBuy campaign.

“With a potential reach of over 1.4 billion consumers with increasing demand for unique travel and shopping experiences, we believe Alipay+ is in the best position to offer an omni-channel and pool resources with our merchants and digital payments partners,” said Dr Cherry Huang, General Manager of Alipay+ Offline Merchant Services at Ant Group. “We hope more businesses can take part in the initiative to help deliver the best #MoneyCannotBuy experiences to consumers and unleash more growth through innovation and collaboration.”

About Alipay+

Alipay+ is a suite of cross-border digital payment, marketing and digitalization solutions that help connect global merchants to consumers. Consumers enjoy seamless payment and a broad choice of deals using their preferred payment methods while travelling abroad. Small and medium-sized businesses may use Alipay+ digital tools to enhance efficiency and achieve omni-channel growth.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media
Sarah Dai
Ant Group
Sarah.dai@antgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye